As the Immunology Value & Access Lead for the GCC Cluster at Sanofi Genzyme, I have over 7 years of experience in developing and implementing value-based and patient-centric strategies to ensure access and affordability of innovative medicines for rare and chronic diseases. I have a strong background in international public health, marketing, public policy analysis, and management and leadership, which enables me to understand and address the diverse and complex challenges and opportunities in the healthcare environment. My core competencies include designing and executing value and access strategies, setting and achieving favorable pricing and reimbursement conditions, generating and communicating robust economic evidence, and integrating market access into the brand planning process. I work collaboratively with cross-functional teams, key stakeholders, and external partners to deliver value propositions that align with the unmet needs, clinical outcomes, and budgetary constraints of different markets. My mission is to ensure that the right patient has access to the right medicine, when and where they need it, at a fair price.